CE Stock Recent News

CE LATEST HEADLINES

CE Stock News Image - Zacks Investment Research

While Celanese (CE) faces challenges from demand softness and pricing pressures, it benefits from strategic acquisitions and productivity measures.

Zacks Investment Research 2024 Apr 12
CE Stock News Image - Zacks Investment Research

Celanese (CE) achieves milestones in cost-effective, sustainable growth, including new facilities and supply contracts, positioning for earnings increase and global expansion.

Zacks Investment Research 2024 Apr 11
CE Stock News Image - Zacks Investment Research

Celanese (CE) benefits from its productivity measures, investments in organic projects and strategic acquisitions.

Zacks Investment Research 2024 Apr 03
CE Stock News Image - Zacks Investment Research

Celanese (CE) now offers low-carbon choices to customers across its Acetyl Chain and Engineered Materials products under the ECO-CC name.

Zacks Investment Research 2024 Mar 25
CE Stock News Image - Zacks Investment Research

Celanese's (CE) collaboration with Secarna enables the development of a novel implant with the potential to significantly alter how disease-modifying ASO treatments are given.

Zacks Investment Research 2024 Mar 22
CE Stock News Image - Zacks Investment Research

Celanese (CE) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research 2024 Mar 21
CE Stock News Image - Zacks Investment Research

While Celanese (CE) faces headwinds from demand softness and pricing pressures, it gains on strategic acquisitions and productivity measures.

Zacks Investment Research 2024 Mar 21
CE Stock News Image - Seeking Alpha

Celanese's acquisition of DuPont's Mobility and Materials division did not bring the expected returns due to a challenging market environment. The company is currently saddled with a large debt and depressed earnings, but management is taking actions to ensure profitability and service the debt. While management is taking the right actions, the current perspective does not outweigh short-term risks.

Seeking Alpha 2024 Mar 10
CE Stock News Image - Zacks Investment Research

iDose TR uses Celanese's (CE) VitalDose EVA. It is approved following the completion of two pivotal trials which demonstrates safety and efficacy.

Zacks Investment Research 2024 Mar 04
CE Stock News Image - Seeking Alpha

Celanese Corporation (CE) Q4 2023 Earnings Call Transcript

Seeking Alpha 2024 Feb 21
10 of 50